As an international peer reviewed journal, the mission of Emerging Microbes & Infections (EMI) is to provide a new integrated forum to allow for the timely dissemination of large amount of information gathered about microbes and infections, especially ones associated with increasing biological and clinical significance and pathogenic frequency.
The sheer volume and complexity of such information has gone beyond the scale and scope of existing specialty journals, and thus EMI is committed to bridging the gap between scientific communities in developed and developing countries where most of the emerging microbes and infections have occurred in recent years.
EMI will cover relevant topics of critical biological and clinical value including, but not limited to:
- Epidemic surveillance
- Clinical manifestation
- Diagnosis and management
- Cellular and molecular pathogenesis
- Innate and acquired immune responses between emerging microbes and their hosts
- Drug discovery
- Vaccine development
EMI will serve microbiologists, clinicians, public health workers, drug and vaccine developers, as well as policy makers by providing them with updated knowledge encompassing microbes and infections emerging in different countries and regions throughout the world.
The 2017 journal metrics for Emerging Microbes & Infections are as follows:
- 2-year Impact Factor: 6.032
- 5-year Impact Factor: 6.225
- Immediacy index: 0.845
- Eigenfactor score: 0.006
- Article Influence Score: 2.142
- Rank: 26/155 (Immunology), 15/125 (Microbiology)